KATRINA LANDRUM: Open Payments
NPI 1962280263 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 22 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $445 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $186 |
| Axsome Therapeutics, Inc. | 3 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, AUSTEDO XR.
Industry payments across MS — which companies pay providers there.
